Health In Tech demonstrates a strong and differentiated core business model centered on AI-driven underwriting and scalable broker distribution, enabling robust recurring revenue growth and expanding market reach. While gross margins have declined due to scaling costs, operating leverage improvemen…
Health In Tech (HIT) Q1 2025: Revenue Surges 56% as AI Underwriting Platform Expands Market Reach
Health In Tech delivered robust top-line growth driven by accelerating demand for its AI-backed underwriting and self-funded healthcare solutions. Strategic partnerships and broker network expansion underpin scalable growth as the company prepares for a major platform rollout targeting larger employers. Momentum positions HIT for sustained market penetration and operational leverage in 2025.
Summary
- Platform Innovation Drives Expansion: AI-powered underwriting platform extends reach into mid-to-large employer market.
- Distribution Efficiency Enhances Scalability: Broker network more than doubled, supporting cost-effective customer acquisition.
- Strategic Partnerships Strengthen Offering: Integration of virtual care services broadens healthcare access and value proposition.
Business Overview
Health In Tech (HIT) operates as an Insurtech platform company leveraging third-party AI technology to streamline healthcare insurance underwriting and program management. The company generates revenue primarily through underwriting fees and program service fees associated with self-funded healthcare plans for small to mid-sized businesses. Its business is segmented into underwriting modeling (ICE), program services (SMR), and an optional HI Card offering that complements the core platform.
Performance Analysis
In Q1 2025, Health In Tech reported total revenues of $8.0 million, a 56% increase year-over-year, fueled by a 17% rise in enrolled employees to 24,307. Underwriting model revenues grew 32% to $2.3 million, while program fee revenues surged nearly 70% to $5.7 million, reflecting clients’ growing willingness to invest in enhanced healthcare benefits. Gross margin declined from 80.7% to 66.8%, driven by increased infrastructure and third-party technology costs associated with platform scaling.
Operating expenses rose by approximately $1.1 million year-over-year to $4.9 million, largely due to $0.6 million in public company costs and $0.5 million in share-based compensation. Despite this, operating expenses as a percentage of revenue improved significantly to 61% from 74% a year earlier, underscoring improved operating leverage. Adjusted EBITDA more than doubled to $1.2 million, and income before income tax expanded 257% to $0.7 million, confirming scalable profitability as the company grows.
- Revenue Mix Shift: Fee-based revenues outpaced underwriting, signaling a strategic emphasis on value-added program services.
- Cost Structure Evolution: Channel distribution model reduced sales and marketing expense ratio by nearly 7 percentage points.
- Balance Sheet Strength: Cash remained strong at $7.6 million with disciplined accounts receivable management supporting liquidity.
Overall, the financial results reflect successful execution of strategic initiatives that balance growth with profitability while building infrastructure for long-term market expansion.
Executive Commentary
"We achieved $8 million in revenue, reflecting 56% year-over-year growth, and generated $0.7 million in income before income tax, a 257% increase compared to the same period last year. The number of enrolled employees on our platforms also rose to 24,307, up from 20,802 in Q1 2024. This performance underscores the strength of our platforms, the effectiveness of our strategic initiatives, and the accelerating demand for our innovative self-funded healthcare solutions."
Tim Johnson, Chief Executive Officer
"Total revenue for first quarter reached 8 million, up 56% year over year. This growth was fueled partially by a 17% increase in total billable enrolled employees. Revenue from underwriting model grew 31.8% to 2.3 million. When the program fee revenue surged 69.5% to 5.7 million. Fee-based revenue continued to outpace underwriting revenue as more employers prioritize high-quality coverage and enhanced service offerings."
Julia Chen, Chief Financial Officer
Strategic Positioning
1. AI-Powered Underwriting Platform Expansion
Since November 2024, HIT has been beta testing its large-group AI-backed underwriting platform targeting employers with 150 to over 1,000 employees. This platform automates and accelerates underwriting by parsing disparate data formats into structured inputs for underwriters, reducing underwriting cycle times by 70% to 80%. The planned full rollout in Q3 will open access to a traditionally underserved segment that lacks comparable technological solutions, substantially increasing the company’s total addressable market.
2. Broker Network Growth and Channel Distribution Model
Active brokers on the HIT platform more than doubled to 459 from 192 a year ago. This expansion supports a channel distribution model that leverages brokers and third-party administrators (TPAs) to drive customer acquisition efficiently. As a result, sales and marketing expenses remained flat in absolute terms while declining as a percentage of revenue, demonstrating scalable growth without proportional cost increases.
3. Strategic Partnership with DialCare
The integration of DialCare’s telehealth and virtual care services into HIT’s self-funded health plans enhances member access to on-demand primary care, therapy, and psychiatric services nationwide. This partnership aligns with HIT’s mission to deliver smarter, accessible healthcare solutions, adding value to the platform’s offerings and supporting cost containment through predictable flat-fee programs.
4. Technology-Driven Risk Mitigation and Program Customization
HIT’s platform creates tailored health insurance programs that help employers manage risk exposure through layered coverage limits and health management initiatives. This approach mitigates loss risk for employers new to self-funding while enabling cost savings and improved employee benefits, differentiating HIT from traditional fully insured plans with limited flexibility.
5. Leadership and Board Expertise
The appointment of Sanjay Shrestha to the board brings seasoned leadership in scaling platform businesses and capital markets expertise. His background in technology and energy sectors adds strategic depth to HIT’s growth ambitions and capital allocation decisions.
Key Considerations
Health In Tech’s Q1 results reflect a successful scaling phase supported by technology innovation and efficient distribution. Key considerations for investors include:
- Market Penetration: The AI underwriting platform rollout targets a large, underserved segment, offering significant growth potential beyond the current small-business focus.
- Operational Leverage: Improved expense ratios signal scalable economics, but continued investment in technology and platform enhancements will be necessary.
- Channel Partner Reliance: Growth depends heavily on broker and TPA engagement, necessitating sustained relationship management and platform usability.
- Competitive Landscape: HIT must maintain technological differentiation as competitors may seek to replicate AI-driven underwriting efficiencies.
- Regulatory and Risk Management: As a platform facilitating self-funded plans, HIT’s ability to manage risk exposure and regulatory compliance remains critical.
Risks
Potential risks include execution challenges in scaling the AI underwriting platform, slower-than-expected adoption by larger employers, and competitive pressures from incumbent insurers and emerging Insurtech firms. Additionally, macroeconomic factors influencing employer healthcare spending and regulatory changes could impact demand and profitability.
Forward Outlook
For Q2 2025, Health In Tech anticipates continued strong sales momentum driven by expanding broker engagement and platform adoption. Management expects to maintain gross margins near current levels, supported by channel distribution efficiencies and ongoing technology investments.
- Revenue growth is projected to remain robust, with a focus on scaling the AI underwriting platform.
- Operating leverage is expected to improve as fixed costs are spread over higher revenue.
For the full year 2025, HIT maintains guidance for sustained double-digit top-line growth and improved profitability, underpinned by strategic initiatives and market expansion efforts.
Takeaways
Health In Tech’s Q1 performance underscores its transition from a niche small-business platform to a scalable, technology-driven enterprise targeting mid-to-large employers. Key takeaways include:
- Platform Differentiation: The AI underwriting system’s ability to reduce underwriting time by up to 80% represents a meaningful competitive advantage that can unlock new market segments.
- Distribution Model Efficiency: Doubling the broker network while holding sales and marketing expenses flat demonstrates effective leverage of channel partners to drive growth.
- Innovation-Driven Growth: Strategic partnerships like DialCare broaden service offerings, enhancing member value and supporting premium program fees.
Conclusion
Health In Tech’s first quarter results reflect strong execution on its strategic roadmap, combining AI innovation, channel expansion, and partnerships to drive accelerated growth and profitability. As the company prepares for a major AI underwriting platform rollout, it is well-positioned to capture a larger share of the self-funded healthcare market.
Industry Read-Through
HIT’s AI-driven underwriting platform and channel-focused distribution model highlight emerging trends in the Insurtech sector towards automation and scalable digital solutions for complex healthcare insurance processes. The integration of virtual care services signals growing convergence between insurance and telehealth, offering a blueprint for other platform providers aiming to enhance member engagement and cost management. Investors and competitors should monitor how AI adoption accelerates underwriting efficiency and reshapes risk management in self-funded healthcare plans.